[1]Chan, K., 2005. Chinese medicinal materials and their interface with Western medical concepts. J. Ethnopharmacol., 96(1-2):1-18.

[2]Chen, Y., Duan, J.A., Guo, J., et al., 2015. Yuanhuapine-induced intestinal and hepatotoxicity were correlated with disturbance of amino acids, lipids, carbohydrate metabolism and gut microflora function: a rat urine metabonomic study. J. Chromatogr. B, in press.

[3]Danan, G., Teschke, R., 2016. RUCAM in drug and herb induced liver injury: the update. Int. J. Mol. Sci., 17(1):14.

[4]Debelle, F.D., Vanherweghem, J.L., Nortier, J.L., 2008. Aristolochic acid nephropathy: a worldwide problem. Kidney Int., 74(2):158-169.

[5]Efferth, T., Kaina, B., 2011. Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr. Drug Metab., 12(10):989-996.

[6]Izumotani, T., Ishimura, E., Tsumura, K., et al., 1993. An adult case of Fanconi syndrome due to a mixture of Chinese crude drugs. Nephron, 65(1):137-140.

[7]Jia, W., Du, F., Liu, X., et al., 2015. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions. Drug Metab. Dispos., 43(5):669-678.

[8]Kong, L.Y., Tan, R.X., 2015. Artemisinin, a miracle of traditional Chinese medicine. Nat. Prod. Rep., 32(12):1617-1621.

[9]Li, D., 2007. Literature review of eighty-five cases of allergy due to usage of traditional Chinese medicine. Fujian Zhongyiyao, 38(3):44-45 (in Chinese).

[10]Nobelprize.org. Nobel Media AB, 2015. The Nobel Prize in Physiology or Medicine 2015—Press Release. Available from http://www.nobelprize.org/nobel_prizes/medicine/laureates/2015/press.html [Accessed on Mar. 17, 2016].

[11]Nyirimigabo, E., Xu, Y.Y., Li, Y.B., et al., 2015. A review on phytochemistry, pharmacology and toxicology studies of Aconitum. J. Pharmacy Pharmacol., 67(1):1-19.

[12]Qiao, H.X., Liu, Y.Y., Wu, L.M., et al., 2007. Nephrotoxicity of Radix Aristolochice and it’s substitution material Radix Inulae in rats. China J. Chin. Mater. Medica, 32(19):2048-2051 (in Chinese).

[13]Sen, P., Ho, M.S., Ng, S.K., et al., 2010. Contact dermatitis: a common adverse reaction to topical traditional Chinese medicine. Int. J. Dermatol., 49(11):1255-1260.

[14]Shaw, D., 2010. Toxicological risks of Chinese herbs. Planta Med., 76(17):2012-2018.

[15]Teschke, R., Eickhoff, A., 2015. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front. Pharmacol., 6:72.

[16]Teschke, R., Wolff, A., Frenzel, C., et al., 2014. Review article: herbal hepatotoxicity—an update on traditional Chinese medicine preparations. Aliment. Pharmacol. Ther., 40(1):32-50.

[17]Teschke, R., Wolff, A., Frenzel, C., et al., 2015. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J. Gastroenterol., 21(15):4466-4490.

[18]US National Library of Medicine, 2014. Chinese and other Asian herbal medicines. Available from http://livertox.nih.gov/ChineseAndOtherAsianHerbalMedicines.htm [Accessed on Dec. 31, 2015].

[19]Wang, D., Qiu, L., Wu, X., et al., 2015. Evaluation of kudzu root extract-induced hepatotoxicity. J. Ethnopharmacol., 176:321-326.

[20]Wang, J.S., van der Heijden, R., Spruit, S., et al., 2009. Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J. Ethnopharmacol., 126(1):31-41.

[21]World Health Organization, 2014. World malaria report 2014. World Health Organization, p.16-18. Available from http://www.who.int/malaria/publications/world_malaria_report_2014/en/ [Accessed on Apr. 27, 2016].

[22]World Health Organization, 2015. Guidelines for the treatment of malaria, 3rd Ed. World Health Organization, Geneva, Switzerland. Available from http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf?ua=1&ua=1 [Accessed on Sep. 10, 2015].

[23]Xu, X.L., Yang, L.J., Jiang, J.G., 2016. Renal toxic ingredients and their toxicology from traditional Chinese medicine. Expert. Opin. Drug Metab. Toxicol., 12(2):149-159.

[24]Zhang, L., Yan, J., Liu, X., et al., 2012. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J. Ethnopharmacol., 140(3):519-525.

[25]Zhao, X., Lu, L., Zhang, Y., et al., 2011. Study on discriminating nephrotoxic components in Zexie. China J. Chin. Mater. Medica, 36(6):758-761 (in Chinese).

[26]Zhong, Y., Menon, M.C., Deng, Y., et al., 2015. Recent advances in traditional Chinese medicine for kidney disease. Am. J. Kidney Dis., 66(3):513-522.